- 4.8Impact Factor
- 7.7CiteScore
- 16 daysTime to First Decision
Special Issues
Pharmaceuticals publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Druggability of Mitochondrial Proteases: Emerging Targets and Therapeutic Opportunities in Cancer and Neurodegeneration
Deadline: 20 December 2026
Click Chemistry-Aided Drug Discovery
Deadline: 15 November 2026
NeuroImmunoEndocrinology
Deadline: 31 October 2026
Molecular Insights and Clinical Implications in Geriatric Medicine and Drug Development
Deadline: 31 October 2026
New Structural, Biophysical and Computational Perspectives on the Use of Proteins in Drug Design and Discovery
Deadline: 31 October 2026
Pharmacotherapy of Thromboembolism
Deadline: 25 October 2026
New Advances in Antiarrhythmic Drugs
Deadline: 20 October 2026
Therapeutic Potential of Silver Nanoparticles (AgNPs), 2nd Edition
Deadline: 30 September 2026
Multi-Targeted Natural Products as Therapeutics, 2nd Edition
Deadline: 30 September 2026
Omics Approaches in Drug Discovery, Precision Therapy, and Disease Prevention
Deadline: 30 September 2026
Pain Management: Novel Biomarkers and Therapeutic Targets
Deadline: 30 September 2026
Recent Advancements in the Development of Antiprotozoal Agents: 2nd Edition
Deadline: 25 September 2026
of 82

